Amgen has provided multi-year support to the Cancer Research Institute across patient education and thought leadership, including Cancer Immunotherapy Month, patient education webinars, and the CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference

In 2016, Amgen’s pioneering leadership in the field of cancer immunotherapy was recognized with the Oliver R. Grace Award, presented to Amgen chairman and chief executive officer Robert A. Bradway at the CRI Annual Awards Dinner.

*Immunotherapy results may vary from patient to patient.